Trastuzumab Deruxtecan in HER2-Low Breast Cancer. | N Engl J Med;387(12): 1143-1144, 2022 09 22. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Trastuzumab Deruxtecan in HER2-Low Breast Cancer.

Schnog, John-John B; Samson, Michael J; Duits, Ashley J.

Schnog JB; Curaçao Medical Center, Willemstad, Curaçao john.schnog@cmc.cw.
Samson MJ; Curaçao Medical Center, Willemstad, Curaçao john.schnog@cmc.cw.
Duits AJ; Curaçao Medical Center, Willemstad, Curaçao john.schnog@cmc.cw.

N Engl J Med ; 387(12): 1143-1144, 2022 09 22.

Article in English | MEDLINE | ID: covidwho-2036972

Subject(s)

Breast Neoplasms; Immunoconjugates; Breast Neoplasms/drug therapy; Camptothecin/analogs & derivatives; Female; Humans; Trastuzumab/therapeutic use

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / Immunoconjugates Limits: Female / Humans Language: English Journal: N Engl J Med Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / Immunoconjugates Limits: Female / Humans Language: English Journal: N Engl J Med Year: 2022 Document Type: Article